1. Treatment of Parkinsonism with L-dopa;Klawans, H.L.; Garvin, J.S.;Diseases of the Nervous System
2. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease;Fabbrini, G.; Juncos, J.; Mouradian, M.M.; Serati, C.; Chase, T.N.;Ann Neurol,1987
3. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease;Kempster, P.A.; Frankel, J.P.; Bovingdon, M.; Webster, R.; Lees, A.J.; Stern, G.M.;J Neurol Neurosurg Psychiatry,1989
4. Does long term aggravation of Parkinson's disease result from non-dopaminergic lesions?;Bonnet, A.M.; Loria, Y.; Saint-Hillaire, M.-H.; Lhermitte, F.; Agid, Y.;Neurology,1987
5. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness;Rogers, D.; Lees, A.J.; Smith, E.; Trimble, M.; Stern, G.M.;Brain,1987